Table IIB.

Host-versus-graft PIRCHE scores (PS) and clinical outcomes: univariate analysis

	Class I PS (Median 10, Range 0–51)			Class II PS (Median 32, Range 0–97)
Outcome	HR	95% CI	P	HR	95% CI	P
aGvHD (Grade II-IV)	1.016	0.996–1.036	0.121	1.003	0.987–1.019	NS
Relapse	1.02 0	0.995–1.046	0.111	1.000	0.986–1.014	NS
Overall Survival	1.015	0.997–1.032	0.106	1.003	0.993–1.013	NS
Relapse-Free Survival	1.014	0.997–1.032	0.111	1.001	0.991–1.011	NS
Treatment-Related Mortality	0.998	0.975–1.022	NS	1.001	0.987–1.015	NS
cGvHD (any)	0.982	0.954–1.011	NS	1.007	0.990–1.023	NS
Neutrophil Engraftment	1.001	0.983–1.013	NS	0.994	0.985–1.003	0.194
Platelet Engraftment	1.001	0.984–1.017	NS	0.998	0.989–1.006	NS

aGvHD indicates acute graft-versus-host disease, while cGvHD indicates chronic graft-versus-host disease. NS (non-significant) indicates a p-value greater than 0.2.